Adding to this, our study now sheds light on the pathophysiology of the T2/FLAIR-mismatch sign, revealing significantly higher ADC and lower rCBV values for IDH-mutant gliomas with the presence of the T2/FLAIR-mismatch sign as compared to those IDH-mutant gliomas without. Here, IDH1 is linked to central nervous system cancer.